Am J Transplant, Volume 20, Suppl 3 Archives - Page 205 of 223 - ATC Abstracts

2020 American Transplant Congress
Severity of Donor Acute Kidney Injury Does Not Impact Long-Term Outcomes in Deceased Donor Renal Transplant Recipients
A. Brar¹, A. Gruessner², D. Adey¹, M. Salifu²
¹University of California, San Francisco, San Francisco, CA, ²SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Kidneys with increased donor terminal creatinine are frequently discarded. This study used national data to assess renal allograft and patient outcomes in deceased donor…
2020 American Transplant Congress
Safety and Efficacy of Direct-Acting Oral Anticoagulants versus Warfarin in Kidney Transplant Recipients
A. L. Bixby¹, S. A. Shaikh², A. S. Naik³, L. Cotiguala³, K. McMurry³, M. D. Samaniego-Picota⁴, V. D. Marshall⁵, J. M. Park³
¹University Hospitals Cleveland Medical Center, Cleveland, OH, ²Keck Medical Center of USC, University of Southern California, Los Angeles, CA, ³Michigan Medicine, Ann Arbor, MI, ⁴Henry Ford Transplant Institute, Detroit, MI, ⁵University of Michigan College of Pharmacy, Ann Arbor, MI
*Purpose: Safety and efficacy of direct-acting oral anticoagulants (DOACs) have not been well studied in solid organ transplant. The purpose of our study was to…
2020 American Transplant Congress
Failure to Launch; a Multi-Centre Study of Potential Live Donors in Southeast Nigeria
C. G. Okwuonu¹, G. O. Achor², Q. L. Ogana³, C. Kingsley⁴
¹Internal Medicine, Federal Medical Centre, Umuahia, Nigeria, ²Department of Surgery, Federal Medical Centre, Umuahia, Nigeria, ³Internal Medicine, Beatitudes Mediplex and Kidney Care Centre, Umuahia, Nigeria, ⁴Internal Medicine, Beatitudes Mediplex and Kidney Care Centre, Aba, Nigeria
*Purpose: To determine the socio-demographic characteristics of potential living kidney donors, donor motivation, incidental findings on clinical evaluation and some identified factors that precluded eventual…
2020 American Transplant Congress
Major Adverse Cardiovascular Events (MACE) in Living Kidney Donors (LKDs)
M. Merzkani¹, A. Denic¹, M. D'Costa¹, L. Ricaurte¹, R. Narasimhan¹, X. Benavides¹, A. Mullan¹, J. Larson¹, W. Park¹, M. P. Alexander¹, H. Chakkera², S. Textor¹, S. Taler¹, M. Stegall¹, N. Issa¹, A. Rule¹
¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Scottsdale, AZ
*Purpose: There is limited knowledge regarding long-term cardiovascular outcomes in living kidney donors. We performed a multicenter study assessing baseline risk factors that increase MACE…
2020 American Transplant Congress
“By the Time They Get to Me, I’ll Be Dead Anyway” – A Mixed-Methods Examination of Treatment Education & Decision-Making among Patients with Varying Amounts of Pre-End-Stage Renal Disease Nephrology Care
M. Urbanski¹, L. Dumenci¹, C. Gadegbeku², L. Siminoff¹, A. Waterman³, H. Gardiner¹
¹College of Public Health, Temple University, Philadelphia, PA, ²Lewis Katz School of Medicine, Section of Nephrology, Hypertension, and Kidney Transplantation, Temple University, Philadelphia, PA, ³UCLA, Division of Nephrology, Los Angeles, CA
*Purpose: The aim of this study was to explore renal replacement therapy (RRT) knowledge and decision-making experiences and preferences among patients with varying amounts of…
2020 American Transplant Congress
Delayed Graft Function in the Recipients of Simultaneous Liver and Kidney Transplant: A Single-Center Experience
F. Aziz, B. Muth, N. Garg, M. Mohamed, D. Mandelbrot, J. Mezrich, A. Djamali, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Increased rates of delayed graft function (DGF) have been reported in the recipients of simultaneous liver and kidney (SLK) transplant. However, the effect of…
2020 American Transplant Congress
HELLP Me! My Liver Ruptured and Nobody Can Give Me Platelets: A Case Study of Liver Transplantation for Liver Rupture from HELLP Syndrome
R. Cooke, M. Williams, M. A. Adams
UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: Liver rupture and infarction are rare but serious complications of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. We report successful utilization…
2020 American Transplant Congress
The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?
D. Yoeli¹, M. Adams¹, R. Choudhury¹, T. Nydam¹, J. Pomposelli¹, J. Goss², M. Wachs¹
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Transplant Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The opioid epidemic afflicting our nation has led to a surge in the number of adult deceased donors from drug overdose. We hypothesized that…
2020 American Transplant Congress
Extracorporeal Membrane Oxygenation in Pediatric Liver Transplantation
I. A. Ziogas¹, W. R. Johnson¹, C. Thurm², M. Hall², L. K. Matsuoka¹, M. I. Montenovo¹, M. D. Bacchetta¹, J. Godown³, S. P. Alexopoulos¹
¹Vanderbilt University Medical Center, Nashville, TN, ²Children's Hospital Association, Lenexa, KS, ³Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN
*Purpose: Extracorporeal membrane oxygenation (ECMO) can be used for oxygen preservation and hemodynamic support in case of circulatory or respiratory failure. Although the role of…
2020 American Transplant Congress
Letermovir for CMV Prophylaxis and Treatment of Resistant/ Refractory CMV Disease in Solid Organ Transplant Recipients
M. Miller¹, S. Scherger², E. Benamu², V. Bajrovic², P. Ramanan², N. Madinger², M. Barron², S. Johnson², T. Campbell², A. Gray³, A. Weinberg⁴, M. Abidi²
¹Clinical Pharmacy, University of Colorado Hospital, Aurora, CO, ²Infectious Diseases, University of Colorado Denver School of Medicine, Aurora, CO, ³Pulmonology, University of Colorado Denver School of Medicine, Aurora, CO, ⁴Pediatrics, University of Colorado Denver School of Medicine, Aurora, CO
*Purpose: Letermovir (LMV) is approved for primary cytomegalovirus (CMV) prophylaxis in hematopoietic cell transplant recipients. Current FDA-approved antiviral options are limited to foscarnet and cidofovir…